Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Pain Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Opioids
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Pain Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.3.4 Hormone Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Pain Market Perspective (2018-2029)
2.2 Cancer Pain Growth Trends by Region
2.2.1 Global Cancer Pain Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Pain Historic Market Size by Region (2018-2024)
2.2.3 Cancer Pain Forecasted Market Size by Region (2024-2029)
2.3 Cancer Pain Market Dynamics
2.3.1 Cancer Pain Industry Trends
2.3.2 Cancer Pain Market Drivers
2.3.3 Cancer Pain Market Challenges
2.3.4 Cancer Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Pain Players by Revenue
3.1.1 Global Top Cancer Pain Players by Revenue (2018-2024)
3.1.2 Global Cancer Pain Revenue Market Share by Players (2018-2024)
3.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Pain Revenue
3.4 Global Cancer Pain Market Concentration Ratio
3.4.1 Global Cancer Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2022
3.5 Cancer Pain Key Players Head office and Area Served
3.6 Key Players Cancer Pain Product Solution and Service
3.7 Date of Enter into Cancer Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Pain Breakdown Data by Type
4.1 Global Cancer Pain Historic Market Size by Type (2018-2024)
4.2 Global Cancer Pain Forecasted Market Size by Type (2024-2029)
5 Cancer Pain Breakdown Data by Application
5.1 Global Cancer Pain Historic Market Size by Application (2018-2024)
5.2 Global Cancer Pain Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Pain Market Size (2018-2029)
6.2 North America Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Pain Market Size by Country (2018-2024)
6.4 North America Cancer Pain Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Pain Market Size (2018-2029)
7.2 Europe Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Pain Market Size by Country (2018-2024)
7.4 Europe Cancer Pain Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Pain Market Size (2018-2029)
8.2 Asia-Pacific Cancer Pain Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Pain Market Size by Region (2018-2024)
8.4 Asia-Pacific Cancer Pain Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Pain Market Size (2018-2029)
9.2 Latin America Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Pain Market Size by Country (2018-2024)
9.4 Latin America Cancer Pain Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Pain Market Size (2018-2029)
10.2 Middle East & Africa Cancer Pain Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Pain Market Size by Country (2018-2024)
10.4 Middle East & Africa Cancer Pain Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioDelivery Science
11.1.1 BioDelivery Science Company Detail
11.1.2 BioDelivery Science Business Overview
11.1.3 BioDelivery Science Cancer Pain Introduction
11.1.4 BioDelivery Science Revenue in Cancer Pain Business (2018-2024)
11.1.5 BioDelivery Science Recent Development
11.2 ProStrakan Group
11.2.1 ProStrakan Group Company Detail
11.2.2 ProStrakan Group Business Overview
11.2.3 ProStrakan Group Cancer Pain Introduction
11.2.4 ProStrakan Group Revenue in Cancer Pain Business (2018-2024)
11.2.5 ProStrakan Group Recent Development
11.3 Teva pharmaceuticals
11.3.1 Teva pharmaceuticals Company Detail
11.3.2 Teva pharmaceuticals Business Overview
11.3.3 Teva pharmaceuticals Cancer Pain Introduction
11.3.4 Teva pharmaceuticals Revenue in Cancer Pain Business (2018-2024)
11.3.5 Teva pharmaceuticals Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Detail
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Cancer Pain Introduction
11.4.4 Eli-Lilly Revenue in Cancer Pain Business (2018-2024)
11.4.5 Eli-Lilly Recent Development
11.5 Grunenthal Group
11.5.1 Grunenthal Group Company Detail
11.5.2 Grunenthal Group Business Overview
11.5.3 Grunenthal Group Cancer Pain Introduction
11.5.4 Grunenthal Group Revenue in Cancer Pain Business (2018-2024)
11.5.5 Grunenthal Group Recent Development
11.6 GW Pharmaceuticals
11.6.1 GW Pharmaceuticals Company Detail
11.6.2 GW Pharmaceuticals Business Overview
11.6.3 GW Pharmaceuticals Cancer Pain Introduction
11.6.4 GW Pharmaceuticals Revenue in Cancer Pain Business (2018-2024)
11.6.5 GW Pharmaceuticals Recent Development
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Company Detail
11.7.2 Johnson＆Johnson Business Overview
11.7.3 Johnson＆Johnson Cancer Pain Introduction
11.7.4 Johnson＆Johnson Revenue in Cancer Pain Business (2018-2024)
11.7.5 Johnson＆Johnson Recent Development
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Company Detail
11.8.2 Meda Pharmaceuticals Business Overview
11.8.3 Meda Pharmaceuticals Cancer Pain Introduction
11.8.4 Meda Pharmaceuticals Revenue in Cancer Pain Business (2018-2024)
11.8.5 Meda Pharmaceuticals Recent Development
11.9 Orexo
11.9.1 Orexo Company Detail
11.9.2 Orexo Business Overview
11.9.3 Orexo Cancer Pain Introduction
11.9.4 Orexo Revenue in Cancer Pain Business (2018-2024)
11.9.5 Orexo Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Cancer Pain Introduction
11.10.4 Sanofi Revenue in Cancer Pain Business (2018-2024)
11.10.5 Sanofi Recent Development
11.11 WEX Pharmaceuticals
11.11.1 WEX Pharmaceuticals Company Detail
11.11.2 WEX Pharmaceuticals Business Overview
11.11.3 WEX Pharmaceuticals Cancer Pain Introduction
11.11.4 WEX Pharmaceuticals Revenue in Cancer Pain Business (2018-2024)
11.11.5 WEX Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Pain Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Opioids
Table 3. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 4. Key Players of Others
Table 5. Global Cancer Pain Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cancer Pain Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Pain Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Cancer Pain Market Share by Region (2018-2024)
Table 9. Global Cancer Pain Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cancer Pain Market Share by Region (2024-2029)
Table 11. Cancer Pain Market Trends
Table 12. Cancer Pain Market Drivers
Table 13. Cancer Pain Market Challenges
Table 14. Cancer Pain Market Restraints
Table 15. Global Cancer Pain Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Cancer Pain Market Share by Players (2018-2024)
Table 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2022)
Table 18. Ranking of Global Top Cancer Pain Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cancer Pain Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Pain Product Solution and Service
Table 22. Date of Enter into Cancer Pain Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Pain Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Cancer Pain Revenue Market Share by Type (2018-2024)
Table 26. Global Cancer Pain Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cancer Pain Revenue Market Share by Type (2024-2029)
Table 28. Global Cancer Pain Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Cancer Pain Revenue Market Share by Application (2018-2024)
Table 30. Global Cancer Pain Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cancer Pain Revenue Market Share by Application (2024-2029)
Table 32. North America Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Cancer Pain Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Cancer Pain Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Cancer Pain Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Cancer Pain Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Cancer Pain Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Cancer Pain Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Cancer Pain Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Cancer Pain Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Cancer Pain Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Cancer Pain Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Cancer Pain Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Cancer Pain Market Size by Country (2024-2029) & (US$ Million)
Table 47. BioDelivery Science Company Detail
Table 48. BioDelivery Science Business Overview
Table 49. BioDelivery Science Cancer Pain Product
Table 50. BioDelivery Science Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 51. BioDelivery Science Recent Development
Table 52. ProStrakan Group Company Detail
Table 53. ProStrakan Group Business Overview
Table 54. ProStrakan Group Cancer Pain Product
Table 55. ProStrakan Group Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 56. ProStrakan Group Recent Development
Table 57. Teva pharmaceuticals Company Detail
Table 58. Teva pharmaceuticals Business Overview
Table 59. Teva pharmaceuticals Cancer Pain Product
Table 60. Teva pharmaceuticals Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 61. Teva pharmaceuticals Recent Development
Table 62. Eli-Lilly Company Detail
Table 63. Eli-Lilly Business Overview
Table 64. Eli-Lilly Cancer Pain Product
Table 65. Eli-Lilly Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 66. Eli-Lilly Recent Development
Table 67. Grunenthal Group Company Detail
Table 68. Grunenthal Group Business Overview
Table 69. Grunenthal Group Cancer Pain Product
Table 70. Grunenthal Group Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 71. Grunenthal Group Recent Development
Table 72. GW Pharmaceuticals Company Detail
Table 73. GW Pharmaceuticals Business Overview
Table 74. GW Pharmaceuticals Cancer Pain Product
Table 75. GW Pharmaceuticals Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 76. GW Pharmaceuticals Recent Development
Table 77. Johnson＆Johnson Company Detail
Table 78. Johnson＆Johnson Business Overview
Table 79. Johnson＆Johnson Cancer Pain Product
Table 80. Johnson＆Johnson Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 81. Johnson＆Johnson Recent Development
Table 82. Meda Pharmaceuticals Company Detail
Table 83. Meda Pharmaceuticals Business Overview
Table 84. Meda Pharmaceuticals Cancer Pain Product
Table 85. Meda Pharmaceuticals Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 86. Meda Pharmaceuticals Recent Development
Table 87. Orexo Company Detail
Table 88. Orexo Business Overview
Table 89. Orexo Cancer Pain Product
Table 90. Orexo Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 91. Orexo Recent Development
Table 92. Sanofi Company Detail
Table 93. Sanofi Business Overview
Table 94. Sanofi Cancer Pain Product
Table 95. Sanofi Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. WEX Pharmaceuticals Company Detail
Table 98. WEX Pharmaceuticals Business Overview
Table 99. WEX Pharmaceuticals Cancer Pain Product
Table 100. WEX Pharmaceuticals Revenue in Cancer Pain Business (2018-2024) & (US$ Million)
Table 101. WEX Pharmaceuticals Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Pain Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Cancer Pain Market Share by Type: 2022 VS 2029
Figure 3. Opioids Features
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 5. Others Features
Figure 6. Global Cancer Pain Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Cancer Pain Market Share by Application: 2022 VS 2029
Figure 8. Radiotherapy Case Studies
Figure 9. Chemotherapy Case Studies
Figure 10. Hormone Therapy Case Studies
Figure 11. Others Case Studies
Figure 12. Cancer Pain Report Years Considered
Figure 13. Global Cancer Pain Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cancer Pain Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cancer Pain Market Share by Region: 2022 VS 2029
Figure 16. Global Cancer Pain Market Share by Players in 2022
Figure 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Pain Revenue in 2022
Figure 19. North America Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cancer Pain Market Share by Country (2018-2029)
Figure 21. United States Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Pain Market Share by Country (2018-2029)
Figure 25. Germany Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cancer Pain Market Share by Region (2018-2029)
Figure 33. China Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cancer Pain Market Share by Country (2018-2029)
Figure 41. Mexico Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cancer Pain Market Share by Country (2018-2029)
Figure 45. Turkey Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cancer Pain Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. BioDelivery Science Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 48. ProStrakan Group Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 49. Teva pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 50. Eli-Lilly Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 51. Grunenthal Group Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 52. GW Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 53. Johnson＆Johnson Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 54. Meda Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 55. Orexo Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 56. Sanofi Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 57. WEX Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed